Tomohiro Tada
Tohoku University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tomohiro Tada.
Journal of Cardiovascular Pharmacology | 2008
Noriko Onoue; Jun Nawata; Tomohiro Tada; Doe Zhulanqiqige; Huan Wang; Koichiro Sugimura; Yoshihiro Fukumoto; Kunio Shirato; Hiroaki Shimokawa
Vascular smooth muscle cell (VSMC) migration plays a pivotal role in the pathogenesis of arteriosclerosis, under influences of various mechanical factors. Thus, we examined whether static pressure promotes VSMC migration and if so, whether Rho-kinase is involved. Rat VSMCs were cultured on chambers coated on fibronectin, vitronectin, laminin, or type IV collagen, under pressure-free conditions and at 90 and 180 mm Hg. In monolayer-wounding assay, VSMC migration was significantly increased after 72 hours at 180 mm Hg on both fibronectin (11.3 ± 3.4-fold vs. pressure-free conditions) and vitronectin (10.6 ± 0.7-fold; both P < 0.05). In Boyden chamber assay, the VSMC migration was again significantly increased at 180 mm Hg on both fibronectin (4.0 ± 0.5-fold) and vitronectin (5.0 ± 0.8-fold; both P < 0.05). Neutralizing antibodies against β1-, β3- and β5-integrins, all of which play an important role in cell migration, significantly inhibited the pressure-promoted VSMC migration. Static pressure also significantly increased Rho-kinase activity in VSMC, as evaluated by the extent of phosphorylation of its downstream substrate, ezrin-radixin-moesin. Fasudil, a selective Rho-kinase inhibitor, significantly suppressed the pressure-promoted VSMC migration with reduced Rho-kinase activity. These results indicate that increased static pressure promotes VSMC migration through the integrin/Rho-kinase signaling, suggesting the therapeutic importance of this mechanism for the treatment of hypertensive vascular diseases.
Cardiovascular Research | 2008
Tomohiro Tada; Jun Nawata; Huan Wang; Noriko Onoue; Doe Zhulanqiqige; Kenta Ito; Koichiro Sugimura; Yoshihiro Fukumoto; Hiroaki Shimokawa
AIMS Clinical studies have suggested that pulsatile pressure is an independent risk factor for atherosclerosis. However, it is unknown whether enhanced pulsatile pressure per se directly accelerates vascular smooth muscle cell (VSMC) migration, an important process of atherosclerosis. METHODS AND RESULTS Using our original Pressure-loading system with a Boyden chamber, we examined the direct effects of variable pressures and pulse rates on migration of rat aortic VSMCs in vitro. High pulse pressure (180/90 mmHg, pulsatile vs. 180 mmHg, static), high mean pressure (180/90 vs. 90/0 mmHg, with the same pulse pressure), wide pulse pressure (190/110 vs. 170/130 mmHg, with the same mean pressure), and high pulse rate (120 vs. 40 per min) significantly accelerated the VSMC migration (1.35, 2.38, 1.38 and 1.27-fold, respectively). The increase in intracellular calcium levels measured by fura-2/AM fluorescence was proportional to the magnitude of pressure loaded. The pressure-promoted VSMC migration was significantly inhibited by a phospholipase-C inhibitor U-73122 or a calmodulin inhibitor W-7. Inositol 1,4,5-trisphosphate receptor blockers 2-aminoethoxydiphenyl borate or xestospongin-C significantly inhibited the VSMC migration, whereas a ryanodine receptor blocker ryanodine had no effects. Furthermore, a calcium channel blocker (CCB), azelnidipine, and an angiotensin type-1 receptor blocker, olmesartan, also significantly inhibited the VSMC migration. CONCLUSION These results provide direct evidence for the pro-atherogenic effects of enhanced pulsatile pressure and also suggest that the anti-atherogenic actions of CCBs and angiotensin type-1 receptor blockers are mediated in part by their direct inhibitory effects on VSMC migration in addition to their anti-hypertensive effects.
Circulation | 2009
Zhulanqiqige Do.e; Yoshihiro Fukumoto; Aya Takaki; Shunsuke Tawara; Junko Ohashi; Makoto Nakano; Tomohiro Tada; Kenya Saji; Kohichiro Sugimura; Hiroshi Fujita; Yasushi Hoshikawa; Jun Nawata; Takashi Kondo; Hiroaki Shimokawa
Circulation | 2008
Nobuyuki Shiba; Mika Matsuki; Jun Takahashi; Tomohiro Tada; Jun Watanabe; Hiroaki Shimokawa
International Journal of Cardiology | 2008
Tomohiro Tada; Nobuyuki Shiba; Jun Watanabe; Mika Matsuki; Yutaka Kagaya; Tsuyoshi Shinozaki; Kunio Shirato; Hiroaki Shimokawa
Japanese Circulation Journal-english Edition | 2008
Nobuyuki Shiba; Kotaro Nochioka; Haruka Kohno; Mika Matsuki; Jun Takahashi; Tomohiro Tada; Yutaka Kagaya; Hiroaki Shimokawa
Circulation | 2008
Nobuyuki Shiba; Kotaro Nochioka; Haruka Kohno; Mika Matsuki; Jun Takahashi; Tomohiro Tada; Yutaka Kagaya; Hiroaki Shimokawa
Tohoku Journal of Experimental Medicine | 2010
Koichiro Sugimura; Yoshihiro Fukumoto; Jun Nawata; Huan Wang; Noriko Onoue; Tomohiro Tada; Kunio Shirato; Hiroaki Shimokawa
Circulation | 2005
Kenya Saji; Masahito Sakuma; Jun Suzuki; Tohru Takahashi; Jun Demachi; Jun Nawata; Osamu Kitamukai; Noriko Onoue; Kouichiro Sugimura; Tomohiro Tada; Shigefumi Fukui; Yutaka Kagaya; Jun Watanabe; Kunio Shirato
Japanese Circulation Journal-english Edition | 2008
Nobuyuki Shiba; Mika Matsuki; Jun Takahashi; Tomohiro Tada; Jun Watanabe; Hiroaki Shimokawa